VIB

Type

CVC

Status

Active

Location

Ghent, Belgium

Total investments

21

Average round size

18M

Portfolio companies

15

Rounds per year

0.78

Follow on index

0.29

Exits

3

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologyHealth CareHealth DiagnosticsMedicalPharmaceuticalTherapeuticsAgTechChemicalBiopharmaAgriculture

Summary

VIB appeared to be the Corporate Investor, which was created in 1996. The company was established in Europe in Belgium. The main department of described Corporate Investor is located in the Gent.

The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the VIB, startups are often financed by Gimv, Qbic, PMV. The meaningful sponsors for the fund in investment in the same round are Gimv, PMV, V-Bio Ventures. In the next rounds fund is usually obtained by Gimv, Sofinnova Partners, Qbic Fund.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight AgroSavfe, GlobalYeast, Aphea.Bio. Among the most successful fund investment fields, there are AgTech, Industrial.

Deals in the range of 10 - 50 millions dollars are the general things for fund. The higher amount of exits for fund were in 2016. This VIB works on 11 percentage points less the average amount of lead investments comparing to the other organizations. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year.

Show more

Investor highlights

Industry focus
Biotech/Life SciencesMedtechAgriculture
Stage focus
Series ASeries B
Geo focus
AlbaniaAustriaBelgiumBosnia and HerzegovinaBulgaria Show 36 more

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
21
Lead investments
0
Exits
3
Rounds per year
0.78
Follow on index
0.29
Investments by industry
  • Biotechnology (19)
  • Health Care (7)
  • Agriculture (6)
  • Health Diagnostics (4)
  • Pharmaceutical (4)
  • Show 9 more
Investments by region
  • Belgium (19)
  • Denmark (1)
  • Brazil (1)
Peak activity year
2020

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
4M
Group Appearance index
1.00
Avg. company exit year
8
Avg. multiplicator
1.56

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Biotalys 09 Mar 2017 Biotechnology, AgTech, Agriculture Early Stage Venture 11M Belgium, East Flanders, Ghent
Dualyx 15 May 2023 Biotechnology, Health Care, Medical Early Stage Venture 47M Oost-Vlaanderen, Ghent, Belgium
VoterTide 01 Feb 2012 Seed 500K United States, Omaha, Nebraska

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.